Answers from the Lab

Paul Jannetto, Ph.D., and Loralie Langman, Ph.D., discuss Mayo Clinic Laboratories’ innovative new assay to detect marijuana, or cannabis, use. Using high-resolution, tandem mass spectrometry, our test identifies metabolites of both delta-9- tetrahydrocannabinol (THC) and delta-8 THC, which are psychoactive compounds found in cannabis plants. Our assay is among the only available tests in the nation to detect for delta-8 THC, which is synthesized from hemp plants and increasing in popularity following 2018 legislation that legalized the compound in most states.

Show Notes

(00:31):
Before we get started, can you tell us a little bit about yourselves and your backgrounds?

(02:35):
Can you guys give us a brief overview of this assay and what will be changing to characterize marijuana use?

(04:28):
So which patients should have this testing and when would you say it should be performed, Dr. Langman?

(05:58):
Are there other test options available and if, and if so, how do these compare?

(07:03):
This is really the best way to accurately characterize marijuana use. Would you say that's true?

(07:11):
And then could you, Dr. Langman, explain how the results are used in patient care?

What is Answers from the Lab?

A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.